recombinant il-6 Search Results


cold air 827 il 6  (R&D Systems)
97
R&D Systems cold air 827 il 6
Cold Air 827 Il 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Human+IL-6+Protein/pm09817153-91-12-16
Average 97 stars, based on 1 article reviews
cold air 827 il 6 - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
human recombinant il  (R&D Systems)
96
R&D Systems human recombinant il
Human Recombinant Il, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Human+IL-6+Protein/pm09828188-36-0-6
Average 96 stars, based on 1 article reviews
human recombinant il - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
recombinant mouse il6  (R&D Systems)
96
R&D Systems recombinant mouse il6
Figure 5. DCs mediate IFNa effects on Treg suppression through <t>IL6.</t> A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or <t>recombinant</t> IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).
Recombinant Mouse Il6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Mouse+IL-6+Protein/10__1158_slash_1078___0432__ccr___20___4594-114-0-3
Average 96 stars, based on 1 article reviews
recombinant mouse il6 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
interleukin 6  (R&D Systems)
95
R&D Systems interleukin 6
Figure 5. DCs mediate IFNa effects on Treg suppression through <t>IL6.</t> A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or <t>recombinant</t> IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).
Interleukin 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Human+IL-6+Protein%2C+CF/10__1074_slash_jbc__m403884200-85-68-70
Average 95 stars, based on 1 article reviews
interleukin 6 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
cf recombinant human il 6 r d systems  (R&D Systems)
91
R&D Systems cf recombinant human il 6 r d systems
Figure 5. DCs mediate IFNa effects on Treg suppression through <t>IL6.</t> A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or <t>recombinant</t> IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).
Cf Recombinant Human Il 6 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Mouse+IL-6%2FIL-6R+alpha+Protein+Chimera/pm36599350-150-56-60
Average 91 stars, based on 1 article reviews
cf recombinant human il 6 r d systems - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
recombinant protein il 6  (Novus Biologicals)
91
Novus Biologicals recombinant protein il 6
Figure 5. DCs mediate IFNa effects on Treg suppression through <t>IL6.</t> A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or <t>recombinant</t> IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).
Recombinant Protein Il 6, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Rat+IL-6+Protein/pm36977695-244-45-49
Average 91 stars, based on 1 article reviews
recombinant protein il 6 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
mouse il 6  (R&D Systems)
96
R&D Systems mouse il 6
Figure 5. DCs mediate IFNa effects on Treg suppression through <t>IL6.</t> A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or <t>recombinant</t> IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).
Mouse Il 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Mouse+IL-6+Protein/pmc05903614-55-50-66
Average 96 stars, based on 1 article reviews
mouse il 6 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
recombinant rat il 6 rril 6  (R&D Systems)
94
R&D Systems recombinant rat il 6 rril 6
Figure 5. DCs mediate IFNa effects on Treg suppression through <t>IL6.</t> A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or <t>recombinant</t> IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).
Recombinant Rat Il 6 Rril 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Rat+IL-6+Protein/pm10799912-39-12-19
Average 94 stars, based on 1 article reviews
recombinant rat il 6 rril 6 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
il 6  (R&D Systems)
95
R&D Systems il 6
Figure 5. DCs mediate IFNa effects on Treg suppression through <t>IL6.</t> A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or <t>recombinant</t> IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).
Il 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Equine+IL-6+Protein%2C+CF/pm16585597-54-5-14
Average 95 stars, based on 1 article reviews
il 6 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
active human recombinant granzyme b  (Danaher Inc)
99
Danaher Inc active human recombinant granzyme b
Figure 5. DCs mediate IFNa effects on Treg suppression through <t>IL6.</t> A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or <t>recombinant</t> IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).
Active Human Recombinant Granzyme B, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+human+IL-6+protein/pmc06351540-189-21-29
Average 99 stars, based on 1 article reviews
active human recombinant granzyme b - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
carrier free recombinant mouse il 6  (R&D Systems)
93
R&D Systems carrier free recombinant mouse il 6
Figure 5. DCs mediate IFNa effects on Treg suppression through <t>IL6.</t> A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or <t>recombinant</t> IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).
Carrier Free Recombinant Mouse Il 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Mouse+IL-6+Protein%2C+CF/pmc05572685-148-16-21
Average 93 stars, based on 1 article reviews
carrier free recombinant mouse il 6 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
il 6 afl206  (R&D Systems)
90
R&D Systems il 6 afl206
Figure 5. DCs mediate IFNa effects on Treg suppression through <t>IL6.</t> A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or <t>recombinant</t> IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).
Il 6 Afl206, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+il-6/Recombinant+Human+IL-6%2C+Animal-Free+Protein/pmc04922693-198-15-20
Average 90 stars, based on 1 article reviews
il 6 afl206 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Figure 5. DCs mediate IFNa effects on Treg suppression through IL6. A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or recombinant IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).

Journal: Clinical Cancer Research

Article Title: IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer

doi: 10.1158/1078-0432.ccr-20-4594

Figure Lengend Snippet: Figure 5. DCs mediate IFNa effects on Treg suppression through IL6. A, Flow cytometric analysis of suppression of T-cell proliferation by Tregs from the PEC of ID8- challenged IFNR/ mice adoptively transferred with WT or IFNR/ DCs and then treated with DD plus IFNa (samples pooled for each experiment, all groups n ¼ 3). B, Luminex analysis of IL6 and IL10 in supernatant with Tregs, DCs and/or IFNa (one of three experiments with similar results). Suppression of T-cell proliferation by Tregs in the presence of DCs, IFNa, and/or anti-IL6 (n ¼ 3 for all groups; C) or in the presence of DCs, IFNa, and/or recombinant IL6 (n ¼ 3 for all groups; D). E, Suppression of T-cell proliferation by Tregs in the presence of DCs, recombinant IL6, anti-CD80 and/or anti-CD86 (n ¼ 3 for all groups). F, Treg function in mLNs of mice challenged with ID8, treated with DDþIFNa PBS or anti-IL6 in vivo (n ¼ 5 for both groups).

Article Snippet: Recombinant mouse IL6 (R&D Systems) at 0.1 or 1.0 mg/mL was added withoutDCs as indicated.

Techniques: Luminex, Recombinant, In Vivo

Figure 7. Pegylated IFNa has activity in the clinical response to failed DD in patients with ovarian cancer. A, CA-125 serum levels in patient 103. IFNa given as weekly, subcutaneous pegylated IFNa2a. B, CA-125 serum levels in patient 105. C, Serum IL6 in patient 103 after treatment with DD alone and after addition of pegylated IFNa2a. Mean of triplicate replicates. D, Flow cytometric analysis of Treg prevalence (CD4þCD25hiCD127lo cells among all blood CD3þCD4þ

Journal: Clinical Cancer Research

Article Title: IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer

doi: 10.1158/1078-0432.ccr-20-4594

Figure Lengend Snippet: Figure 7. Pegylated IFNa has activity in the clinical response to failed DD in patients with ovarian cancer. A, CA-125 serum levels in patient 103. IFNa given as weekly, subcutaneous pegylated IFNa2a. B, CA-125 serum levels in patient 105. C, Serum IL6 in patient 103 after treatment with DD alone and after addition of pegylated IFNa2a. Mean of triplicate replicates. D, Flow cytometric analysis of Treg prevalence (CD4þCD25hiCD127lo cells among all blood CD3þCD4þ

Article Snippet: Recombinant mouse IL6 (R&D Systems) at 0.1 or 1.0 mg/mL was added withoutDCs as indicated.

Techniques: Activity Assay